Meanwhile, RNA interference (RNAi) and CRISPR/Cas9 gene-editing technologies have been widely employed to validate METTL1 function, demonstrating that silencing or knockout of METTL1 can significantly suppress tumor cell proliferation and migration. Here, METTL1 is linked to neoplasm.